SYX-5219

N/A

Report date: 2026/05/06 20:02:28
NMEFirst In Class

Base Information

Drug NameSYX-5219
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase isozymes M1/M2 activatorsImmunomodulators
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesDenmark +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSitryx Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSitryx Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A